Welcome to our dedicated page for Amerisafe SEC filings (Ticker: AMSF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AMERISAFE, Inc. filings document formal disclosures for a Nasdaq-listed specialty workers’ compensation insurer focused on high-hazard industries. Form 8-K reports cover financial results, dividend announcements, the reauthorization of a common stock repurchase program and executive officer changes, including related employment-agreement disclosures.
The company’s proxy materials cover annual meeting matters, director elections, board governance, executive compensation and shareholder voting items. Cover-page disclosures identify AMERISAFE common stock, par value $0.01 per share, traded under AMSF on the Nasdaq Stock Market.
AMERISAFE, Inc. appointed Guillermo A. Ramos as Executive Vice President and Chief Financial Officer, effective May 7, 2026. He joins from Hiscox US, where he served as Head of Finance Strategy and Senior Vice President, and previously held senior finance roles at Equifax.
Ramos entered a three-year employment agreement with automatic one-year renewals, a base salary of at least $500,000, eligibility for incentive plans, and customary severance if terminated without cause, including 12 months of salary and average bonus. He will also receive restricted stock units valued at $1,000,000 under AMERISAFE’s 2022 Equity and Incentive Compensation Plan.
AMERISAFE, Inc. is soliciting proxies for its 2026 annual meeting to be held June 10, 2026, at its DeRidder, Louisiana headquarters. Shareholders of record as of April 16, 2026 may vote on election of three directors, advisory approval of executive compensation, ratification of Ernst & Young as auditor, and two certificate of formation amendments.
The Board recommends shareholder approval of an officer exculpation amendment and several technical and conforming amendments. The proxy includes 2025 performance metrics: net income $47.1M, diluted EPS $2.47, combined ratio 91.3%, and total 2025 dividends of $2.56 per share (including a $1.00 extraordinary dividend).
AMERISAFE, Inc. filed an initial statement of beneficial ownership for executive Henry O. Lestage IV, who serves as Executive Vice President and Chief Claims Officer. The Form 3 does not report any share purchases, sales, or other transactions, indicating this is a baseline ownership disclosure rather than a trading event.
AMERISAFE Inc ownership filing: The Vanguard Group amended its Schedule 13G to report 0 shares beneficially owned of Common Stock, representing 0% of the class. The amendment states Vanguard reorganized on January 12, 2026 and now reports certain subsidiaries separately in reliance on SEC Release No. 34-39538.
AMERISAFE Inc. executive vice president and Chief Risk Officer Vincent J. Gagliano received a grant of 6,392 shares of common stock on March 12, 2026 at no cost as equity compensation. To cover tax obligations, 2,708 shares were withheld at $32.92 per share, leaving him with 31,523 shares held directly after these transactions.
AMERISAFE INC executive Kathryn Shirley Housh reported routine equity compensation activity. On March 12, 2026, she received a grant of 5,905 shares of common stock at a price of 0.0000 per share as part of a grant or award.
On the same date, 2,501 shares were disposed of at 32.9200 per share to satisfy tax withholding obligations, a non-market transaction coded as a tax-liability payment. After these transactions, she directly holds 24,751 shares of AMERISAFE common stock.
AMERISAFE EVP–CSO Raymond F. Wise Jr. received a grant of 5,694 shares of common stock on March 12, 2026 at no cost, increasing his holdings to 9,029 shares before related taxes. To cover tax obligations, 2,468 shares were withheld at a price of $32.92 per share, leaving him with 6,561 shares held directly.
AMERISAFE INC President & CEO Janelle Frost reported routine equity compensation activity. She received a grant of 24,814 shares of common stock at no cost, increasing her direct holdings before tax actions. On the same date, 10,509 shares were disposed of to cover tax obligations at a price of $32.92 per share, which is not an open-market sale. After these transactions, she directly owns 129,531 shares of AMERISAFE common stock.
AMERISAFE, Inc. executive Vincent J. Gagliano, EVP and Chief Risk Officer, received a grant of 2,386 restricted stock units. Each unit represents a contingent right to receive one share of Amerisafe common stock and the award fully vests on March 1, 2029.
Following this compensation grant, Gagliano holds 5,234 restricted stock units in total. The Form 4 classifies the transaction as a grant or award acquisition rather than an open-market purchase or sale of shares.
Wise Raymond F. Jr. reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE Inc. Executive Vice President and Chief Sales Officer Raymond F. Wise Jr. received a grant of 2,225 restricted stock units as equity compensation. Each unit represents a contingent right to receive one share of AMERISAFE common stock. Following this award, he now directly holds 14,135 restricted stock units. The newly granted units are scheduled to fully vest on March 1, 2029, meaning the underlying shares will only be delivered if the vesting conditions are satisfied over time.